More
norepinephrine
Therapeutic Class:
Vasopressors
Features: Preservative-free, latex-free, DEHP-free, PVC-free and sulfite-free
| NDC# | Configuration description | Strength | Container type | units/ case | Expiry dating | Product image | Order now |
|---|---|---|---|---|---|---|---|
70324-552-01 | 4 mg Norepinephrine in 0.9% Sodium Chloride Injection 250 mL (16 mcg/mL) (sulfite-free) | 4 mg per 250 mL | Blow-Fill-Seal (BFS) IV bag | 12 | 360-day Room Temperature (RT) |  | |
70324-577-01 | 8 mg Norepinephrine in 0.9% Sodium Chloride Injection 250 mL (32 mcg/mL) (sulfite-free) | 8 mg per 250 mL | BFS IV bag | 12 | 360-day (RT) | | |
70324-602-01 | 16 mg Norepinephrine in 0.9% Sodium Chloride Injection 250 mL (64 mcg/mL) (sulfite-free) | 16 mg per 250 mL | BFS IV bag | 12 | 360-day (RT) | | |
70324-702-01 | 32 mg Norepinephrine in 0.9% Sodium Chloride Injection 250 mL (128 mcg/mL) (sulfite-free) | 32 mg per 250 mL | BFS IV bag | 12 | 360-day (RT) | |
NDC#
70324-552-01
Configuration description
4 mg Norepinephrine
in 0.9% Sodium Chloride Injection
250 mL (16 mcg/mL)
(sulfite-free)
Product image
Preview
Strength
4 mg per 250 mL
Container type
Blow-Fill-Seal (BFS) IV bag
units/ case
12
Expiry dating
360-day Room Temperature (RT)
NDC#
70324-577-01
Configuration description
8 mg Norepinephrine
in 0.9% Sodium Chloride Injection
250 mL (32 mcg/mL)
(sulfite-free)
Product image
Preview
Strength
8 mg per 250 mL
Container type
BFS IV bag
units/ case
12
Expiry dating
360-day (RT)
NDC#
70324-602-01
Configuration description
16 mg Norepinephrine
in 0.9% Sodium Chloride Injection
250 mL (64 mcg/mL)
(sulfite-free)
Product image
Preview
Strength
16 mg per 250 mL
Container type
BFS IV bag
units/ case
12
Expiry dating
360-day (RT)
NDC#
70324-702-01
Configuration description
32 mg Norepinephrine
in 0.9% Sodium Chloride Injection
250 mL (128 mcg/mL)
(sulfite-free)
Product image
Preview
Strength
32 mg per 250 mL
Container type
BFS IV bag
units/ case
12
Expiry dating
360-day (RT)